Dr. Isabelle Lefere – radioloog
0507.770.452 · rovalta.com · 26/09/2026
NORMAL SITUATION
Dr. Isabelle Lefere – radioloog
Company — Normal situation.
Financial year 2025 · Closed on 30/06/2025
Net result132,2 k €+1 923,1 %over 1 year
Gross margin180 k €+5 915,5 %over 1 year
Equity821,8 k €-42,2 %over 1 year
Overview
Identity
Source · BCE/KBODr. Isabelle Lefere – radioloog is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0507.770.452
- Legal form
- Private company with limited liability
- Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2025
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 12 filingsTrend over 11 financial years
| 2025 | 2024 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 180 k € | +5916% | -3,1 k € | -100% | 1,1 M € | +117% | 486 k € | +12.3% | 432,6 k € |
| EBITDA | 179,9 k € | +4567% | -4 k € | -100% | 1,1 M € | +118% | 484 k € | +12.4% | 430,5 k € |
| Operating result | 179,9 k € | +2616% | -7,1 k € | -101% | 1 M € | +125% | 456,4 k € | +10.5% | 413 k € |
| Net result | 132,2 k € | +1923% | -7,3 k € | -101% | 705,2 k € | +124% | 314,4 k € | +0.5% | 312,7 k € |
| Balance sheet | |||||||||
| Equity | 821,8 k € | -42.2% | 1,4 M € | +14.7% | 1,2 M € | +131% | 536,4 k € | +141% | 222,8 k € |
| Total assets | 831 k € | -45.6% | 1,5 M € | +12.7% | 1,4 M € | +45.9% | 929,4 k € | +16.4% | 798,2 k € |
| Cash | 489,5 k € | -13.5% | 566,1 k € | +9.8% | 515,7 k € | +0.3% | 514,1 k € | +37.9% | 372,8 k € |
| Debts | 9,2 k € | -91.0% | 102,7 k € | -10.9% | 115,2 k € | -70.7% | 393,1 k € | -31.7% | 575,4 k € |
Board of directors
Source · NBB, accounts to 30/06/20251 active · 3 ended
Active mandates
Isabelle Lefere
ActiveEnded mandates
Isabelle Julie Lefere
EndedIsabelle Lefere
EndedIsabelle Lefere
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 27/09/2024 | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 |
| Closing of the financial year | 30/06/2025 | 26/09/2024 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 |
| Length of the financial year | 10 months | 3 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/09/2025 | 17/12/2024 | 25/11/2024 | 08/01/2024 | 23/01/2023 | 20/12/2021 |
| General meeting | 31/08/2025 | 26/09/2024 | 21/09/2024 | 09/12/2023 | 10/12/2022 | 11/12/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 31/08/2025 | 17/09/2025 | Dutch | |
| Micro model | 26/09/2024 | 26/09/2024 | 17/12/2024 | Dutch | |
| Micro model | 30/06/2024 | 21/09/2024 | 25/11/2024 | Dutch | |
| Micro model | 30/06/2023 | 09/12/2023 | 08/01/2024 | Dutch | |
| Micro model | 30/06/2022 | 10/12/2022 | 23/01/2023 | Dutch | |
| Micro model | 30/06/2021 | 11/12/2021 | 20/12/2021 | Dutch | |
| Micro model | 30/06/2020 | 09/10/2020 | 03/12/2020 | Dutch | |
| Micro model | 30/06/2019 | 14/12/2019 | 10/01/2020 | Dutch | |
| Micro model | 30/06/2018 | 08/12/2018 | 12/12/2018 | Dutch | |
| Micro model | 30/06/2017 | 09/12/2017 | 15/01/2018 | Dutch | |
| Abridged model | 30/06/2016 | 10/12/2016 | 13/01/2017 | Dutch | |
| Abridged model | 30/06/2015 | 12/12/2015 | 21/12/2015 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active · 3 ended
Active mandates
Isabelle Lefere
ActiveEnded mandates
Isabelle Julie Lefere
EndedIsabelle Lefere
EndedIsabelle Lefere
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution20/01/2026RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
- Dissolution22/10/2024RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - ONTSLAGEN - BENOEMINGEN
- Registered office24/03/2016MAATSCHAPPELIJKE ZETEL
- Other31/12/2014RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025132,2 k €↑
- 2024Annual accounts 2024-7,3 k €↓
- 2024Annual accounts 2024705,2 k €↑
- 2024Name changeDr. Isabelle Lefere - Radioloog (in vereffening)
- 2023Annual accounts 2023314,4 k €↑
- 2022Annual accounts 2022312,7 k €↓
- 2022Name changeDr. Isabelle Lefere - Radioloog
- 2020Annual accounts 2020319,8 k €↑
- 2019Annual accounts 2019315,1 k €↑
- 2018Annual accounts 2018159,6 k €↑
- 2017Annual accounts 201749,4 k €↑
- 2016Annual accounts 2016-22 k €↓
- 2015Annual accounts 201517,2 k €